Sign in to fuzzto save your conversations, follow your research and come back anytime.
Cohance Lifesciences
SectorHealthcare
| Metric (₹ crore) | Q4 FY19 | Q1 FY20 | Q2 FY20 | Q3 FY20 | Q4 FY20 | Q1 FY21 | Q2 FY21 | Q3 FY21 | Q4 FY21 | Q1 FY22 | Q2 FY22 | Q3 FY22 | Q4 FY22 | Q1 FY23 | Q2 FY23 | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 250.92 | 197.39 | 272.93 | 178.71 | 184.76 | 238.23 | 237.39 | 274.93 | 259.16 | 263.8 | 300.99 | 391.59 | 363.85 | 338.8 | 278.4 | 353.77 | 369.36 | 347.55 | 231.05 | 219.82 | 252.93 | 488.08 | 603.77 | 676.23 | 840.42 | 549.31 | 555.57 | 544.55 | 619.12 | 422.26 |
| Expenses | 128.91 | 94.93 | 147.44 | 99.15 | 108.2 | 126.15 | 139.52 | 137.61 | 165.47 | 149.19 | 179.21 | 205.56 | 206.83 | 187.92 | 178.52 | 207.08 | 197.49 | 180.58 | 133.09 | 153.74 | 179.59 | 362.98 | 398.4 | 438.86 | 611.2 | 437.3 | 434.62 | 449.2 | 520.44 | 421.1 |
| EBITDA | 122.01 | 102.46 | 125.49 | 79.56 | 76.56 | 112.08 | 97.87 | 137.32 | 93.69 | 114.61 | 121.78 | 186.03 | 157.02 | 150.88 | 99.88 | 146.69 | 171.87 | 166.97 | 97.96 | 66.08 | 73.34 | 125.1 | 205.37 | 237.37 | 229.22 | 112.01 | 120.95 | 95.35 | 98.68 | 1.16 |
| Depreciation | 5.96 | 5.5 | 5.53 | 5.51 | 6.96 | 7.06 | 7.5 | 8.76 | 8.31 | 8.99 | 9.18 | 10.51 | 10.42 | 11.5 | 12.03 | 12.24 | 12.02 | 12.54 | 11.89 | 12.79 | 17.25 | 31.28 | 37.79 | 43.56 | 54.17 | 45.14 | 44.02 | 46.94 | 51.23 | 49.54 |
| EBIT | 116.05 | 96.96 | 119.96 | 74.05 | 69.6 | 105.02 | 90.37 | 128.56 | 85.38 | 105.62 | 112.6 | 175.52 | 146.6 | 139.38 | 87.85 | 134.45 | 159.85 | 154.43 | 86.07 | 53.29 | 56.09 | 93.82 | 167.58 | 193.81 | 175.05 | 66.87 | 76.93 | 48.41 | 47.45 | -48.38 |
| Interest | 1.74 | 3.82 | 4.42 | 7.61 | 6.53 | 3.21 | 2.64 | 1.91 | 1.87 | 2.13 | 1.18 | 0.74 | 2.19 | 1.45 | 0.29 | 1.38 | 5.03 | 1.15 | 0.5 | 2.16 | 2.3 | 10.2 | 9.61 | 10.8 | 10.45 | 10.18 | 8.76 | 9.11 | 9.19 | 6.74 |
| Profit Before Tax | 114.31 | 93.14 | 115.54 | 66.44 | 63.07 | 101.81 | 87.73 | 126.65 | 83.51 | 103.49 | 111.42 | 174.78 | 144.41 | 137.93 | 87.56 | 133.07 | 154.82 | 153.28 | 85.57 | 51.13 | 53.79 | 83.62 | 157.97 | 183.01 | 164.6 | 56.69 | 68.17 | 39.3 | 38.26 | -55.12 |
| Net Profit | 74.82 | 91.9 | 93 | 57.91 | 74.18 | 91.52 | 74.08 | 113.63 | 83.12 | 105.08 | 96.98 | 160.07 | 91.67 | 107.54 | 72.06 | 107.72 | 123.97 | 120.59 | 79.56 | 46.75 | 53.37 | 75.37 | 138.24 | 153.48 | 117.15 | 46.4 | 66.39 | 29.02 | 8.31 | -45.19 |
| EPS | 5.88 | 7.22 | 3.65 | 4.55 | 5.83 | 3.6 | 2.91 | 4.46 | 3.27 | 4.13 | 3.81 | 6.29 | 3.6 | 4.22 | 2.83 | 4.23 | 4.87 | 4.74 | 3.13 | 1.84 | 2.1 | 1.98 | 3.63 | 4.02 | 3.16 | 1.28 | 1.94 | 0.96 | 0.51 | -0.63 |
| Metric (₹ crore) | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 50.4 | 406.92 | 382.55 | 330 | 457.2 | 358.48 | 673.35 | 368.32 |
| Investing Cash Flow | -65.48 | -413.45 | -311.4 | -136.21 | -195.01 | -362.25 | -387.62 | -250.68 |
| Financing Cash Flow | 25.98 | 7.32 | -75.66 | -156.41 | -241.95 | -13.8 | -327.4 | -165.15 |
| Net Cash Flow | 10.9 | 0.79 | -4.51 | 37.38 | 20.24 | -17.57 | -41.67 | -47.51 |
| Metric (₹ crore) | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Equity / Shareholders' Funds | 590.29 | 844.76 | 1,180.8 | 1,527.18 | 1,735.18 | 2,050.66 | 3,792.88 | 4,033.83 |
| Total Liabilities | 192.73 | 328.05 | 293.68 | 302.41 | 230.56 | 203.42 | 1,688.08 | 1,695.81 |
| Total Assets | 783.02 | 1,172.81 | 1,474.48 | 1,829.59 | 1,965.74 | 2,254.09 | 5,480.96 | 5,729.64 |